News

A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.
Unless you are from another planet, you’ve heard all about the new weight loss medications taking the world by storm. These ...
Manhattan-based dentist Dr. Sandip Sachar and obesity medicine specialist Dr. Meghan Garcia-Webb discuss the prevalence of ...
Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related ...
According to ophthalmologist Bradley Katz, PhD, the study’s lead author, vision issues are already a comorbidity related to diabetes. However, the GLP-1 medications might also be responsible for ...